---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-012063"
form_type: "8-K"
ticker: "MRKR"
cik: "0001094038"
company_name: "Marker Therapeutics, Inc."
filed_at: "2026-02-09T23:59:59+00:00"
generated_at: "2026-05-16T03:48:45.197335+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Marker Therapeutics sets 2026 annual meeting for May 1; shareholder proposals due March 9

## Summary
- 2026 Annual Meeting scheduled for May 1, 2026, moving more than 30 days from 2025 meeting date.
- Shareholder proposals under Rule 14a-8 must be received by March 9, 2026, at company's Houston offices.
- Record date and meeting details to be included in the upcoming proxy statement.

## SEC filing metadata
- accession: 0001104659-26-012063
- form_type: 8-K
- ticker: MRKR
- cik: 0001094038
- company_name: Marker Therapeutics, Inc.
- filed_at: 2026-02-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- confidence: high
- sec_items: 5.08, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1094038/000110465926012063/0001104659-26-012063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1094038/000110465926012063/tm265663d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-012063
- JSON: https://secwatch.observer/filing/0001104659-26-012063.json
- Plain text: https://secwatch.observer/filing/0001104659-26-012063.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.